Academic Department of Trauma & Orthopaedic Surgery, Clarendon Wing, Floor A, Great George Street, Leeds General Infirmary, LS1 3EX Leeds, UK.
Surgeon. 2012 Aug;10(4):230-9. doi: 10.1016/j.surge.2012.04.001. Epub 2012 Jun 6.
Currently, a number of bone grafting materials are available in the clinical setting to enhance bone regeneration, varying from autologous bone to several bone graft substitutes. Although autologous bone remains the "gold standard" for stimulating bone repair and regeneration, the morbidity from its harvesting and its restricted availability generated the need for the development of other materials or strategies either to substitute autologous bone graft or expand its limited supply. Bone graft substitutes can possess one or more components: an osteoconductive matrix, acting as a scaffold; osteoinductive proteins and other growth factors to induce differentiation and proliferation of bone-forming cells; and osteogenic cells for bone formation. Based on their distinct properties, all these bone grafting alternatives have specific indications, and can be used either alone or in combination. In this review, we summarise the available bone grafting materials, focussing mainly on the various bone substitutes and their characteristics, in an effort to specify the indications for their use.
目前,临床上有许多种骨移植材料可用于增强骨再生,从自体骨到几种骨移植替代物不等。虽然自体骨仍然是刺激骨修复和再生的“金标准”,但其采集的发病率和有限的可用性促使人们开发其他材料或策略,要么替代自体骨移植,要么扩大其有限的供应。骨移植替代物可以具有一个或多个成分:作为支架的骨传导基质;诱导成骨细胞分化和增殖的骨诱导蛋白和其他生长因子;以及用于骨形成的成骨细胞。基于其不同的特性,所有这些骨移植替代物都有特定的适应证,可以单独使用或联合使用。在这篇综述中,我们总结了现有的骨移植材料,主要集中在各种骨替代物及其特性上,努力明确其使用的适应证。